Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

ClinicalTrials.gov ID: NCT00118066

Public ClinicalTrials.gov record NCT00118066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase II Trial Of Calcitriol In Patients With Prostatic Intraepithelial Neoplasia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of calcitriol may prevent prostate cancer. It is not yet known whether calcitriol is more effective than observation in preventing prostate cancer. PURPOSE: This randomized phase II trial is studying how well calcitriol works in preventing prostate cancer in patients with prostatic intraepithelial neoplasia.

Study identification

NCT ID
NCT00118066
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
12 participants

Conditions and interventions

Interventions

Dietary Supplement · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2004 (Type not available)
Primary completion
Jun 2011 (Actual)
Completion
Aug 2011 (Actual)
Last update posted
May 27, 2015

2004 – 2011

United States locations

U.S. sites
5
U.S. states
1
U.S. cities
4
Facility City State ZIP Site status
Central Jersey Oncology Center, PA - East Brunswick East Brunswick New Jersey 08816 —
Carol G. Simon Cancer Center at Morristown Memorial Hospital Morristown New Jersey 07962 —
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick New Jersey 08903 —
Saint Peter's University Hospital New Brunswick New Jersey 08903 —
Overlook Hospital Summit New Jersey 07901 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00118066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 27, 2015 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00118066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →